1 / 1

Healthcare Reimbursement Landscape China: JSB Market Research

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure.<br><br>For more information: http://bit.ly/28WDmlf

richa21
Download Presentation

Healthcare Reimbursement Landscape China: JSB Market Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. REFERENCE CODE GDHC0052CHR | PUBLICATION DATE JANUARY 2016 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China Channel sales partner China's Medical Device Market Will Burgeon Beyond $50 Billion by 2020 Medical Device Market, China, Revenue ($bn), 2008–2020 60 50 40 Revenue ($bn) 30 20 10 0 2008 2014 2017 2020 Source: GlobalData, Medical eTrack [Accessed on September 16, 2015] The Chinese medical device market is set to rise from $27.7 billion in 2014 to an estimated $50.8 billion by 2020, expanding at a strong Compound Annual Growth Rate (CAGR) of 10.6%. This substantial increase will be driven by a number of factors, including the increasing prevalence of metabolic syndromes and chronic diseases, an aging population, as well as government investment. These factors are all linked, as an aging population will lead to increased incidences of chronic diseases such as respiratory diseases, cancers and cardiovascular disease. This will provide medical device manufacturers with opportunities for growth. The leading device companies in China who will benefit are Siemens Healthcare, GE Healthcare, Philips Healthcare, Medtronic and Roche. The dominant player in terms of revenue in China is Siemens, which has a best-in-class portfolio of ultrasound and medical imaging solutions. click to purchase - http://www.jsbmarketresearch.com/healthcare-medical/r-countryfocus-healthcare-regulatory-and-reimbursement-landscape-china-235363 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form.

More Related